Biologics
-
Notice of Lattice Biologics Ltd. Second Quarter 2016 Financial Results Conference Call
SCOTTSDALE, AZ–(Marketwired – May 20, 2016) – Lattice Biologics Ltd. (TSX VENTURE:LBL) (OTCBB: BLVKF) (the “Company”) announced today it will release…
Read More » -
Biologics
VTI Announces Launch of InterGraft™ Biologics
MINNETONKA, MN (PRWEB) MAY 19, 2016 Vertebral Technologies, Inc. (VTI), a company focused on developing minimally invasive (MIS) modular solutions…
Read More » -
Lattice Biologics Preparing to Launch Three New Products Featuring Matrix-Assisted Regeneration (MAR) Technology
SCOTTSDALE, AZ–(Marketwired – April 18, 2016) – Lattice Biologics Ltd. (TSX VENTURE:LBL) (OTCBB: BLVKF) (Lattice Biologics) to launch three new…
Read More » -
Financial
Bone Biologics Completes $5.75 Million Round Of Financing
BOSTON, /PRNewswire/ — Bone Biologics (OTCQB: BBLG), an orthobiologic company focused on regenerative medicine, announced today the completion of a $5.75…
Read More » -
Lattice Biologics Offering Exclusive Access to Revolutionary High-Throughput Precision Chemotherapy Screening for Breast Cancer
SCOTTSDALE, AZ–(Marketwired – April 15, 2016) – Lattice Biologics Ltd. (TSX VENTURE:LBL) (OTCBB: BLVKF) is offering select breast reconstruction surgeons…
Read More » -
Financial
Lattice Biologics First Quarter 2016 Highlights
Lattice Biologics Ltd. (TSX VENTURE: LBL)(“Lattice Biologics” or the “Company”) announces financial results for the first quarter ended December 31,…
Read More » -
Spine
New Medical Device Company Launches with Spinal Implants and Biologics
Nvision, a medical device and biologics developer and manufacturer focused on spinal implants, announces its launch with four initial proprietary…
Read More » -
Biologics
Titan Spine Earns Orthopedics This Week 2015 Spine Technology Award
MEQUON, Wisc.–(BUSINESS WIRE)–Titan Spine, a medical device surface technology company focused on developing innovative spinal interbody fusion implants, today announced…
Read More » -
Biologics
NovaBone Receives Notice of Allowance on Fourth New Collagen Patent
JACKSONVILLE, Fla.–(BUSINESS WIRE)–NovaBone Products, a leading biologics medical device company, today announces that the U.S. Patent and Trademark Office (USPTO)…
Read More » -
Recon
3D Printing, Stem Cells Blur the Lines of MedTech
By Sean Fenske Once upon a time, long ago, identifying what we covered in the pages of MDT was a…
Read More » -
Biologics
The orthobiologics market in Asia is estimated to grow to around $703.9 million by 2018 – New Report by MicroMarket Monitor
The orthobiologics market in Asia is estimated to grow to around $703.9 million by 2018, at a developing CAGR of…
Read More » -
Biologics
Amedica Announces Termination of Biologic Distribution Agreement
Amedica Corporation AMDA +2.68% , a commercial biomaterial company focused on using its Silicon Nitride technology platform to develop, manufacture and sell a…
Read More » -
ISTO assumes full control of Zimmer cartilage implant
ISTO Technologies Inc. announced an agreement with Zimmer Holdings Inc. giving ISTO full control of the DeNovo ET Engineered Tissue…
Read More » -
Pioneer® Surgical Technology, Inc. Announces the Expansion of its North Carolina Biomanufacturing Facility
Pioneer Surgical Technology today announces the grand opening of its newly expanded Greenville manufacturing facility. The location houses the primary manufacturing…
Read More » -
Arthrosurface Performs First Biological Knee Procedure
FRANKLIN, Mass., Dec. 17, 2010 /PRNewswire/ — Arthrosurface, Inc. (www.arthrosurface.com), the developer of less-invasive joint resurfacing systems, announced that it…
Read More »